Doceree Inc.

Doceree is an AI-powered operating system for healthcare marketing, dedicated to connecting pharmaceutical and life sciences organizations with healthcare professionals (HCPs) through programmatic advertising. The company's mission is to transform healthcare marketing by enhancing the efficiency and effectiveness of physician engagement, ultimately aiming to improve global health outcomes and reduce healthcare costs. Doceree's primary US headquarters are located in Short Hills, New Jersey, with additional offices in the UK and India.

Doceree offers a comprehensive suite of solutions, including programmatic marketing, point-of-care (POC) engagement, and account-based marketing (ABM). Its platform leverages proprietary identity-resolution technology, such as ESPYIAN, to enable targeted advertising within electronic health record (EHR) systems, telehealth platforms, and other HCP workflows. Key products and services include Co-pay.com, Data IQ, Marketplace, Reptwin, Trial, Spark for clinical screens, and AdManager for publishers. The company serves pharmaceutical companies, medical device manufacturers, and healthcare brands across North America, Europe, the Middle East, Africa, and Asia-Pacific.

Founded by Harshit Jain, MD, and Daleep Manhas, Doceree is privately held and has secured $35 million in Series B funding as of September 2023. Recent developments include the launch of "Spark for DOOH" in March 2026, extending healthcare intelligence to clinical screens, and the creation of the world's largest network of specialist medical publishers in January 2026. Doceree positions itself as the world's first AI-powered operating system for healthcare marketing, trusted by over 115 pharma brands and 30+ agencies, reaching more than 6 million verified HCPs globally.